The global hormone replacement therapy market is set to register a CAGR of 7.67% between 2021 and 2028, and is anticipated to generate revenue of $32132.7 million by 2028. Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of hypothyroidism, menopause, male hypogonadism, and growth hormone deficiency.

GLOBAL HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

Global Hormone Replacement Therapy Market by Therapy Type (Estrogen Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Progestogen Hormone Replacement Therapy) Market by Indication (Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism, Other Indications) Market by Route of Administration (Oral, Parenteral, Transdermal, Other Route of Administrations) by Geography.

Request free sample

Report Summary

The global hormone replacement therapy market is set to register a CAGR of 7.67% between 2021 and 2028, and is anticipated to generate revenue of $32132.7 million by 2028. Hormone replacement therapy (HRT) is a treatment used to relieve symptoms of hypothyroidism, menopause, male hypogonadism, and growth hormone deficiency. hormone-replacement-therapy-market

To learn more about this report, request a free sample copy

Key factors propelling the global hormone replacement therapy market growth are:

  • Prevailing awareness about post-menopausal issues among women
  • Incidence of hormonal disorders
    • The rising incidence of growth hormone-related disorders, such as Prader-Willi Syndrome, is expected to drive market growth.
    • Moreover, as per the National Menopause Foundation, around 65% of women face symptoms of menopause interfering with their quality of life, and 75% of women experience hot flashes during menopause. Hence, the incidence of hormonal disorders is anticipated to boost the market growth during the forecast period.
  • Product launches by major players

Major growth restraining factors:

  • Adverse reactions associated with hormone replacement therapy
  • High cost of treatment
    • The price of the hormones alone can range from $45 to $150 per month. This cost includes high-quality medications, customized treatment plans, and follow-up appointments.
    • Thus, the high cost of treatment is projected to drive the market growth during the forecast period.

The report scope of the global hormone replacement therapy market includes the segmentation analysis of therapy type, indication, and route of administration.

Market by Indication:

  • Menopause
    • Menopause is the major segment in the indication category of the market.
    • The replacement therapy of estrogen is used in women during hysterectomy or post-menopause and helps them sustain the hormonal balance.
  • Male Hypogonadism
  • Growth Hormone Deficiency
    • Growth hormone deficiency is the fastest-growing segment in the indication category in the global market.
    • Human growth hormone is produced by the pituitary gland. A decrease in these hormones results in short growth in children and adolescents.
  • Hypothyroidism
  • Other Indications

Geographically, the global hormone replacement therapy market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • The North American market was the largest market for HRT during the forecast period, and is estimated to witness a lucrative market share over the forecast period.
    • The rising elderly population in the U.S. contributes to the growing incidence rate of disorders, such as menopause, hypogonadism, and hypothyroidism, which are further expected to boost the market growth.
  • Europe: Germany, The United Kingdom, Russia, France, Italy, Belgium, Poland, and Rest of Europe
  • Asia Pacific: Vietnam, India, China, Australia & New Zealand, South Korea, Japan, Thailand, Indonesia, and Rest of Asia Pacific
  • Rest of World: Latin America, the Middle East & Africa

Some major players in the global hormone replacement therapy market are:

  • Abbott Laboratories
  • Bayer AG
  • Novartis AG
  • Pfizer Inc

Key strategies adopted by some of the HRT companies:

In April 2021, an initial agreement was being signed by Novartis to reserve capacity and instrument the transfer of technology for the manufacture of the active pharmaceutical ingredient for Roche’s Actemra or RoActemra.

Key findings of the global hormone replacement therapy market:

  • Changing lifestyles are supplementing the growth of the market.
  • The availability of alternative therapy offers potential growth opportunities.
  • Telemedicine services enable better access to hormone replacement therapy.

Frequently Asked Questions (FAQs):

  • How are the primary healthcare centers beneficial to the hormone replacement therapy (HRT) market growth?

A: The increasing awareness of hormonal replacement therapy has been witnessed among females attending primary healthcare centers in many countries globally. Thus, many primary healthcare centers provide HRT services, thereby promoting the market growth.

  • Why is there an increased demand for hormone replacement therapy?

A: There have been growing hormone replacement therapies due to increased patients experiencing menopause and those with a deficiency of growth hormones. Hormone replacement drugs treat the conditions associated with menopause.

  • How are the advancements in technology boosting the demand for hormone replacement therapy (HRT)?

A: New drug delivery systems offer great flexibility since these authorize localized treatment of specific tissues and controlled release methods for systemic delivery. Hence, the introduction of new drug delivery systems is significantly impacting the market growth during the forecast period.

Table of Contents

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • PREVAILING AWARENESS ABOUT POST-MENOPAUSAL ISSUES AMONG WOMEN
      • INCIDENCE OF HORMONAL DISORDERS
      • PRODUCT LAUNCHES BY MAJOR PLAYERS
    • KEY RESTRAINTS
      • ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
      • HIGH COST OF TREATMENT
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRY
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY THERAPY TYPE
    • ESTROGEN HORMONE REPLACEMENT THERAPY
    • THYROID HORMONE REPLACEMENT THERAPY
    • TESTOSTERONE HORMONE REPLACEMENT THERAPY
    • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
    • PROGESTOGEN HORMONE REPLACEMENT THERAPY
  3. MARKET BY INDICATION
    • MENOPAUSE
    • MALE HYPOGONADISM
    • GROWTH HORMONE DEFICIENCY
    • HYPOTHYROIDISM
    • OTHER INDICATIONS
  4. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • PARENTERAL
    • TRANSDERMAL
    • OTHER ROUTE OF ADMINISTRATIONS
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGE
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    • COMPANY PROFILES
      • ABBOTT LABORATORIES
      • AMGEN
      • ANI PHARMACEUTICALS
      • BAYER AG
      • ELI LILLY & COMPANY
      • GENENTECH INC
      • IPSEN
      • MERCK KGAA
      • NOVARTIS AG
      • NOVEN PHARMACEUTICALS INC
      • NOVO NORDISK A/S
      • PFIZER INC
      • VIATRIS INC (MYLAN NV)

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – HORMONE REPLACEMENT THERAPY

TABLE 2: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL ESTROGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL ESTROGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL THYROID HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL THYROID HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL TESTOSTERONE HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL TESTOSTERONE HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL HUMAN GROWTH HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL HUMAN GROWTH HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL PROGESTOGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL PROGESTOGEN HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL MENOPAUSE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL MENOPAUSE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL MALE HYPOGONADISM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL MALE HYPOGONADISM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL GROWTH HORMONE DEFICIENCY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL GROWTH HORMONE DEFICIENCY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL HYPOTHYROIDISM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL HYPOTHYROIDISM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL OTHER INDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL OTHER INDICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL ORAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL ORAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL PARENTERAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL PARENTERAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL TRANSDERMAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL TRANSDERMAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL OTHER ROUTE OF ADMINISTRATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL OTHER ROUTE OF ADMINISTRATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS 2021-2028 (IN $ MILLION)

TABLE 38: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: LEADING PLAYERS OPERATING IN NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET

TABLE 41: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 42: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 43: LEADING PLAYERS OPERATING IN EUROPE HORMONE REPLACEMENT THERAPY MARKET

TABLE 44: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: LEADING PLAYERS OPERATING IN ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET

TABLE 47: REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 48: REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 49: LEADING PLAYERS OPERATING IN REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET

TABLE 50: LIST OF MERGERS & ACQUISITIONS

TABLE 51: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 52: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 53: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, IN 2020

FIGURE 6: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, IN 2020

FIGURE 12: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, IN 2020

FIGURE 18: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTE OF ADMINISTRATIONS, 2021-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 23: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 24: CANADA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 25: EUROPE HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 26: GERMANY HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: FRANCE HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: ITALY HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: RUSSIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: BELGIUM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: POLAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: REST OF EUROPE HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 35: CHINA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: JAPAN HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: INDIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: AUSTRALIA & NEW ZEALAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: INDONESIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: THAILAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: VIETNAM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: REST OF ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: REST OF WORLD HORMONE REPLACEMENT THERAPY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 45: LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

Segmentation

  1. MARKET BY THERAPY TYPE
    • ESTROGEN HORMONE REPLACEMENT THERAPY
    • THYROID HORMONE REPLACEMENT THERAPY
    • TESTOSTERONE HORMONE REPLACEMENT THERAPY
    • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
    • PROGESTOGEN HORMONE REPLACEMENT THERAPY
  2. MARKET BY INDICATION
    • MENOPAUSE
    • MALE HYPOGONADISM
    • GROWTH HORMONE DEFICIENCY
    • HYPOTHYROIDISM
    • OTHER INDICATIONS
  3. MARKET BY ROUTE OF ADMINISTRATION
    • ORAL
    • PARENTERAL
    • TRANSDERMAL
    • OTHER ROUTE OF ADMINISTRATIONS
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • GERMANY
        • FRANCE
        • UNITED KINGDOM
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGE
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

 

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Choose License Type

    Get In Touch

    Inquire Before Buying

    Customization

    Inkwood Research delivers customized reports as per the client's requirement to provide them with an edge in the competitive market

    Request Customization

    RELATED REPORTS